KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 176 filers reported holding KITE PHARMA INC in Q1 2016. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $12,227,000 | +74.7% | 68,000 | +0.7% | 0.56% | +59.8% |
| Q2 2017 | $6,998,000 | +33.1% | 67,500 | +0.7% | 0.35% | +16.5% |
| Q1 2017 | $5,259,000 | +48.5% | 67,000 | -15.2% | 0.30% | +27.8% |
| Q4 2016 | $3,542,000 | -19.7% | 79,000 | 0.0% | 0.24% | -14.4% |
| Q3 2016 | $4,413,000 | +10.3% | 79,000 | -1.2% | 0.28% | -6.4% |
| Q2 2016 | $4,000,000 | +8.9% | 80,000 | 0.0% | 0.30% | -3.9% |
| Q1 2016 | $3,673,000 | -25.5% | 80,000 | 0.0% | 0.31% | -17.6% |
| Q4 2015 | $4,930,000 | -3.2% | 80,000 | -12.6% | 0.37% | -9.7% |
| Q3 2015 | $5,095,000 | -29.2% | 91,500 | -22.5% | 0.41% | -21.1% |
| Q2 2015 | $7,194,000 | +74.5% | 118,000 | +65.1% | 0.52% | +36.0% |
| Q1 2015 | $4,123,000 | -37.5% | 71,474 | -37.6% | 0.39% | -50.0% |
| Q4 2014 | $6,602,000 | +180.8% | 114,474 | +38.8% | 0.77% | +112.1% |
| Q3 2014 | $2,351,000 | – | 82,474 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|